[The development of co-amorphous drug systems]

Area of Science:

• Pharmaceutical Science
• Materials Science

Background:

• Poorly water-soluble crystalline drugs present challenges in formulation and bioavailability.
• Co-amorphous systems offer a strategy to overcome poor solubility and improve drug delivery.
• The co-administration of multiple drugs often requires specialized formulation approaches.

Purpose of the Study:

• To investigate the conversion of poorly water-soluble drugs into co-amorphous systems.
• To evaluate the impact of co-amorphous formation on drug stability and dissolution rates.
• To explore the theoretical analysis of co-amorphous systems at a molecular level.

Main Methods:

• Co-amorphous systems were prepared using ball milling, quench-cooling, and cryo-milling.
• Formation and intermolecular interactions were characterized using differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), Raman spectroscopy (RS), and Fourier transform infrared spectroscopy (FT-IR).
• Theoretical analysis involved calculating glass transition temperature (Tg) using the Gordon-Taylor equation and interaction parameter (x) using the Flory-Huggins equation.

Main Results:

• Co-amorphous drug systems demonstrated improved drug stability and enhanced dissolution rates compared to single crystalline drugs.
• Characterization techniques confirmed the formation of co-amorphous systems and provided insights into intermolecular interactions.
• Theoretical calculations offered a molecular-level understanding of co-amorphous system properties.

Conclusions:

• Co-amorphous drug systems represent a promising strategy for improving the performance of poorly water-soluble drugs.
• These systems facilitate the co-administration of multiple drugs, addressing a significant challenge in pharmacotherapy.
• The study provides a theoretical framework for analyzing co-amorphous systems, aiding in future drug development.